Will artificial intelligence reverse the trend?, By 2030, there will be a 13% labor shortage in the global healthcare industry. Artificial intelligence | healthcare | labor

Release time:Apr 14, 2024 03:35 AM

The medical industry is undergoing significant changes. At the 2023 World Artificial Intelligence Conference, a third-party market research report from GE Medical, a globally renowned medical equipment and device company, showed that healthcare professionals in multiple countries around the world experience occupational burnout, with 61% of clinical doctors believing that artificial intelligence can support clinical decision-making. 66% of Chinese doctors recognize that artificial intelligence can be used in the medical field, ranking first among surveyed countries. Doctors and patients worldwide are calling for the establishment of a more humane and caring service system to meet more medical needs.

The World Health Organization previously predicted that there will be a global large-scale labor crisis in the healthcare industry, with a 13% labor shortage by 2030. In addition, the global population aged 60 and above is expected to reach 1.4 billion, which will lead to an already overwhelmed healthcare system carrying more burden.

GE Healthcare led a third-party market research report conducted from August to October last year in 8 countries including China, India, and New Zealand. The study randomly sampled 2000 clinical doctors, 5500 patients, and patient rights advocates to conduct an online double-blind survey. Research has found that many clinical doctors are in a period of occupational burnout. 42% of doctors consider giving up working in the medical industry, 44% do not appreciate gratitude from patients and family members, 39% lack a sense of achievement in their work, and 49% of clinical doctors have not experienced seamless medical technology in their medical institutions, leading to work duplication. On the patient side, 44% lack confidence in timely access to medical services, 42% lack trust in the healthcare system's ability to provide affordable medical services, and 37% lack confidence in obtaining the necessary treatment.

How to provide clinical doctors with greater satisfaction and sense of achievement in their work? What changes can data and technology bring to the healthcare system? Research has found that artificial intelligence is no longer just a promise for the future. 66% of Chinese doctors believe that artificial intelligence can be used in the medical field, ranking first in the surveyed countries. However, 55% of doctors worldwide still believe that artificial intelligence is not yet sufficient to be applied in the medical field, and 58% do not trust artificial intelligence data, with greater skepticism coming from clinical doctors with over 16 years of experience.

Establish a more humane and caring healthcare system, and conduct research in four directions. Firstly, shift from isolated to collaborative healthcare services. In the face of a highly differentiated healthcare system, providing high-quality medical services and creating a positive and efficient service experience require collaborative cooperation. Secondly, shift from centralized to flexible healthcare pathways. Due to constantly changing demands and increasing expectations, hospitals are facing great pressure to provide patients with the services they need in a more flexible manner at the time and place they need. Furthermore, shifting from manual to intelligent workflows. Low workflow efficiency is not conducive to providing efficient medical services, and teams need to learn to utilize interoperable smart devices and systems to make data-driven patient care policies. Finally, shift from regular to personalized medical services to meet the personalized needs of more patients.

In order to actively respond to the above trends, at this year's World Artificial Intelligence Conference, GE Healthcare, based on Edison Ecology 2.0, brought a series of digital overall solutions including intelligent devices, intelligent clinical, and intelligent management, empowering doctors to make more efficient and accurate diagnosis and treatment decisions in different medical scenarios, and achieving a comprehensive and precise medical ecosystem from disease screening, diagnosis, treatment to monitoring.

Chief Technology Officer Sun Xuguang's final introduction: Since the launch of Edison's digital medical intelligence platform in 2019, the "ecological circle of friends" built around it has continued to expand. Currently, it has introduced 36 partners and will further enrich the depth and breadth of artificial intelligence applications in the medical field. For example, expanding the service field of artificial intelligence from enhancing imaging, improving standardized ultrasound operation level, to intelligent operating room applications, accelerating the construction of integrated diagnosis and treatment capabilities, assisting the end-to-end intelligent development of clinical practice, solving the severe challenges of domestic medical resource shortage, imbalance, and low efficiency, and ultimately helping to achieve precision medicine.

Why is "Cancer King" immunotherapy ineffective? Fudan Cancer Hospital Reveals New Mechanisms of Immunosuppressive Environment for pancreatic cancer CRIP1 | Tumor | pancreatic cancer
Why is "Cancer King" immunotherapy ineffective? Fudan Cancer Hospital Reveals New Mechanisms of Immunosuppressive Environment for pancreatic cancer CRIP1 | Tumor | pancreatic cancer

Immunotherapy has been proven to achieve significant therapeutic effects in various solid tumors. However, for pancreatic cancer, known as the "king of cancer", immunotherapy has been ineffective. On August 4, Professor Yu Xianjun, Dean of the Cancer Hospital Affiliated to Fudan University, and Shi Si, Associate Professor of Pancreatic Surgery released a research achievement, which first found the key role of cysteine rich protein 1 in shaping the immunosuppressive microenvironment of pancreatic cancer, filled the gap in the research field of immunosuppressive microenvironment of pancreatic cancer, and provided a theoretical basis for precise immunotherapy of pancreatic cancer patients. Ductal adenocarcinoma of the pancreas is the main type of pancreatic cancer, accounting for about 90% of all pancreatic cancer. Due to its high malignancy and poor treatment effectiveness, pancreatic ductal adenocarcinoma has always been one of the most malignant tumors. In recent years, the level of surgical techniques and comprehensive treatment has been achieved

A 14-year-old girl suffers from a rare eye disease and receives support from a public welfare fund. Symptoms of "I haven't looked in the mirror for a long time" | Patient | Public welfare
A 14-year-old girl suffers from a rare eye disease and receives support from a public welfare fund. Symptoms of "I haven't looked in the mirror for a long time" | Patient | Public welfare

A 14-year-old girl has been experiencing symptoms such as protruding pupils, incomplete eye closure, corneal injury, restricted eye movement, and overall fatigue for several years. The physical discomfort and facial abnormalities caused by eye diseases have made her increasingly reticent, and her temperament is vastly different from before. At the Ophthalmology Department of the Ninth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, the pupil has been diagnosed with a rare thyroid ophthalmopathy combined with myasthenia gravis, which requires prompt treatment. However, considering the young age of the pupil, conventional hormone and radiation therapy cannot be used. Therefore, Zhou Huifang, Deputy Director of Ophthalmology and thyroid ophthalmology expert, has developed a targeted drug combined with surgical treatment plan for it, and targeted drug treatment will be performed first. Three months ago, I was hospitalized for one week with mydriasis and received intravenous targeted drug treatment. Afterwards, I went home for observation and followed up on time

The municipal eye disease prevention and treatment center launched the dry eye diagnosis and treatment studio, and the incidence rate of dry eye in China is about 21% to 30% of the meibomian gland | dry eye | eye disease
The municipal eye disease prevention and treatment center launched the dry eye diagnosis and treatment studio, and the incidence rate of dry eye in China is about 21% to 30% of the meibomian gland | dry eye | eye disease

According to the Statistics of Chinese Dry Eye Expert Consensus, the incidence rate of dry eye in China is about 21%~30%, and it is estimated that there are at least 300 million patients nationwide. The Dry Eye Diagnosis and Treatment Studio of Shanghai Eye Disease Prevention and Treatment Center was officially launched today. In the future, the studio will continuously improve the dry eye diagnosis and treatment standards, and form standardized diagnosis and treatment concepts and service models. Suitable technologies will be promoted to the community, allowing residents to enjoy convenient dry eye diagnosis and treatment services at their doorstep. Executive Dean and Party Secretary Gao Wei stated that this is also one of the livelihood service measures recently launched by the hospital around high-quality development and meeting the needs of the people. It is reported that dry eye syndrome is a chronic ocular surface disease caused by multiple factors. The instability of the tear film or imbalance of the ocular surface microenvironment caused by abnormal quality, quantity, and dynamics of tears can be accompanied by ocular surface inflammatory reactions, tissue damage, and nerve abnormalities, resulting in various discomforts in the eyes

The Ninth Hospital has taken the lead in formulating the world's first consensus on core indicators for clinical evaluation of dental implants, which has been officially published in clinical practice
The Ninth Hospital has taken the lead in formulating the world's first consensus on core indicators for clinical evaluation of dental implants, which has been officially published in clinical practice

The International Dental Implant Consensus Report, jointly written by the Ninth People's Hospital affiliated with Shanghai Jiao Tong University School of Medicine and renowned universities in the field of dentistry such as Harvard University, University of Zurich, University of Gothenburg, Columbia University, and University of Frankfurt, has recently been jointly published in top journals in the field of dentistry, including Clinical Periodontology and Clinical Dental Implant Research. This consensus has for the first time established an internationally unified core set of indicators for evaluating the clinical effectiveness of dental implants, covering the five key areas of the field of dental implants. It is of milestone significance for carrying out standardized clinical diagnosis, treatment, and research on dental implants. The core evaluation indicators determined by this consensus will become an important benchmark for scholars in the field of dental implants worldwide to conduct high-quality research. The consensus is composed of 8 top international experts in the field of oral implantation

Recently, autologous hematopoietic stem cell therapy was completed in Shanghai, and British girls born in the 1990s have suffered from multiple relapses of blood diseases, including stem cells, peripheral blood, and diseases
Recently, autologous hematopoietic stem cell therapy was completed in Shanghai, and British girls born in the 1990s have suffered from multiple relapses of blood diseases, including stem cells, peripheral blood, and diseases

Recently, Catherine, a British girl born in the 1990s, received autologous peripheral blood hematopoietic stem cell transfusion at the Cancer Center of Shanghai Jiahui International Hospital, and was successfully discharged from the warehouse. She is now on her way back to China after being discharged from the hospital. She is also the first patient at Shanghai Jiahui International Hospital to complete relevant treatments. In 2019, Catherine was diagnosed with Hodgkin's lymphoma in the UK, and after treatment, the disease completely improved. During her work and life in China in 2021, she went to seek medical attention due to multiple enlarged lymph nodes. Pathological biopsy confirmed a recurrence of Hodgkin's lymphoma, and through combined targeted drug treatment, her condition was temporarily under control. Last year in the second half of the year, when the disease recurred, the girl began to use immunotherapy combined with targeted drugs for treatment. Expert evaluation suggests that for young patients with hematological tumors, the risk of recurrence is high and treatment difficulty is increasing in the future. Autologous hematopoietic stem cell therapy is recommended